Ingalls & Snyder LLC lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 64,134 shares of the company’s stock after selling 1,558 shares during the period. Ingalls & Snyder LLC’s holdings in AstraZeneca were […]